Chandu Sadasivan
Overview
Explore the profile of Chandu Sadasivan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sadasivan C, Gagnon L, Ma C, Dion J, Kim D, Oudit G
JACC Case Rep
. 2025 Mar;
30(5):103191.
PMID: 40054907
Stroke-heart syndrome describes the neurocardiogenic mechanisms that lead to the development of poststroke cardiovascular complications. We describe a 25-year-old man with Carvajal syndrome who developed advanced biventricular heart failure 2 ...
2.
3.
Sadasivan C, Gagnon L, Hazra D, Wang K, Youngson E, Thomas J, et al.
ESC Heart Fail
. 2024 Dec;
PMID: 39740200
Aims: Patients with cardiomyopathies are a heterogeneous group of patients who experience high morbidity and mortality. Early cardiac assessment and intervention with access to genetic counselling in a multidisciplinary Cardiomyopathy...
4.
Gagnon L, Hazra D, Perera K, Wang K, Kashyap N, Sadasivan C, et al.
Am Heart J
. 2024 Apr;
274:11-22.
PMID: 38670300
Background: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are effective in adults with diabetes mellitus (DM) and heart failure (HF) based on randomized clinical trials. We compared SGLT2 inhibitor uptake and outcomes in...
5.
Sadasivan C, Kubinec C, Ao P, Captan V
Intern Med J
. 2023 Oct;
53(10):1929-1930.
PMID: 37859539
No abstract available.
6.
Zhabyeyev P, Sadasivan C, Shah S, Wang F, Oudit G
Front Cardiovasc Med
. 2023 May;
10:1129349.
PMID: 37153462
Background: Iron overload cardiomyopathy (IOC) is a major co-morbidity of genetic hemochromatosis and secondary iron overload with limited therapeutic options. We aim to investigate mechanisms of rescue action of amlodipine...
7.
Gagnon L, Sadasivan C, Yogasundaram H, Oudit G
Curr Heart Fail Rep
. 2022 Sep;
19(6):458-466.
PMID: 36167917
Purpose Of Review: The coronavirus disease 2019 (COVID-19) pandemic has popularized the usage of hydroxychloroquine and chloroquine (HCQ/CQ) as treatments for COVID-19. Previously used as anti-malarial and now commonly used...
8.
Gagnon L, Sadasivan C, Perera K, Oudit G
Can J Cardiol
. 2021 Nov;
38(9):1331-1341.
PMID: 34737034
Cardiovascular complications from drugs of abuse are becoming more apparent because of increased usage worldwide. Substance abuse can cause acute and chronic cardiovascular complications and is increasing in prevalence especially...
9.
Lim K, Sadasivan C, Oudit G
Can J Cardiol
. 2021 Jul;
37(11):1699-1701.
PMID: 34217810
No abstract available.
10.
Sadasivan C, Zhabyeyev P, Labib D, White J, Paterson D, Oudit G
Clin Sci (Lond)
. 2020 Oct;
134(19):2595-2622.
PMID: 33063821
The phosphoinositide 3-kinases (PI3Ks) are a family of intracellular lipid kinases that phosphorylate the 3'-hydroxyl group of inositol membrane lipids, resulting in the production of phosphatidylinositol 3,4,5-trisphosphate from phosphatidylinositol 4,5-bisphosphate....